PTO- 1581 |
Approved for use through 12/31/2020. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 88757457 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 109 |
MARK SECTION | |
MARK | GERON (see, http://uspto.report/TM/88757457/mark.png) |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | GERON |
OWNER SECTION (current) | |
NAME | Geron Corporation |
MAILING ADDRESS | 919 E. Hillsdale Blvd., Suite 250 |
CITY | Foster City |
STATE | California |
ZIP/POSTAL CODE | 94404 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
OWNER SECTION (proposed) | |
NAME | Geron Corporation |
MAILING ADDRESS | 919 E. Hillsdale Blvd., Suite 250 |
CITY | Foster City |
STATE | California |
ZIP/POSTAL CODE | 94404 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
CORRESPONDENCE INFORMATION (current) | |
NAME | Rochelle D. Alpert |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | rochelle.alpert@morganlewis.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | sftrademarks@morganlewis.com |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | Rochelle D. Alpert |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | rochelle.alpert@morganlewis.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | sftrademarks@morganlewis.com |
DOCKET/REFERENCE NUMBER | 058901.2200 |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 005 |
CURRENT IDENTIFICATION | Therapeutic, diagnostic, and prophylactic preparations, pharmaceutical products and agents for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancers and hematologic diseases, syndromes and disorders |
GOODS OR SERVICES | KEEP ALL LISTED |
INTERNATIONAL CLASS | 035 |
CURRENT IDENTIFICATION | Promoting collaboration within the scientific, research and provider communities to achieve advances in the fields of treatment, diagnosis and prophylaxis of cancers and hematologic diseases, syndromes and disorders |
GOODS OR SERVICES | KEEP ALL LISTED |
INTERNATIONAL CLASS | 042 |
CURRENT IDENTIFICATION | Providing medical information in the field of the diagnosis and treatment of cancers and hematologic malignancies to consumers, and providing medical information in the field of prevention, screening, diagnosis and treatment to scientists, researchers and medical providers on cancers and hematologic diseases, syndromes and disorders |
GOODS OR SERVICES | KEEP ALL LISTED |
EXTENSION SECTION | |
EXTENSION NUMBER | 1 |
ALLOWANCE MAIL DATE | 07/21/2020 |
STATEMENT OF USE | NO |
PAYMENT SECTION | |
NUMBER OF CLASSES | 3 |
SUBTOTAL AMOUNT [EXTENSION FEE] | 375 |
TOTAL AMOUNT | 375 |
SIGNATURE SECTION | |
SIGNATURE | /rda/ |
SIGNATORY'S NAME | Rochelle D. Alpert |
SIGNATORY'S POSITION | Attorney of Record for Applicant, CA State Bar |
DATE SIGNED | 01/19/2021 |
SIGNATORY'S PHONE NUMBER | 415 442-1326 |
SIGNATURE METHOD | Signed directly within the form |
FILING INFORMATION | |
SUBMIT DATE | Tue Jan 19 20:27:58 ET 2021 |
TEAS STAMP | USPTO/ESU-XXX.XXX.XXX.XX- 20210119202758251012-8875 7457-7603584fbccd3c16bc0a 21d99dc985f8c2272fe359a4f 5a9edd9af52c4c2da2ff-DA-2 7563656-20210119202510975 108 |
PTO- 1581 |
Approved for use through 12/31/2020. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |